​

Funding Round

Venture Round - Iconic Therapeutics

Venture Round - Iconic Therapeutics

Investment Firm

Overview

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.

Announced Date

Jun 15, 2018

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

N/A

Participant Investors

11

Investor Name
Participant InvestorHBM Partners
Participant InvestorElm Street Ventures
Participant InvestorOUP (Osage University Partners)
Participant InvestorH.I.G. BioHealth Partners
Participant InvestorATDC

Round Details and Background

Iconic Therapeutics raised $4110000 on 2018-06-15 in Venture Round

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 30, 2007
Venture Round - Iconic Therapeutics
1-1.3M
Aug 22, 2011
Venture Round - Iconic Therapeutics
1-undefined
Apr 16, 2014
Series B - Iconic Therapeutics
3-20.0M
Jan 17, 2009
Venture Round - Iconic Therapeutics
2-2.5M

Recent Activity

There is no recent news or activity for this profile.